Regulation and interplay of apoptotic and non‐apoptotic cell death
Open Access
- 1 November 2005
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (3) , 319-326
- https://doi.org/10.1002/path.1885
Abstract
Various death triggers including DNA damage, oxidative stress, and growth factor deprivation promote the loss of mitochondrial membrane potential, leading to the production of reactive oxidative species (ROS) or enhanced permeability of the mitochondrial membrane, otherwise known as mitochondrial membrane permeabilization, by insertion of Bax/Bak into the outer membrane where it interacts with voltage‐dependent anion channel (VDAC)/adenine nucleotide transporter (ANT). MMP leads to the release of small pro‐apoptotic molecules, which induce caspase‐dependent and ‐independent apoptotic cell death. The production of ROS due to the loss of mitochondrial membrane potential enhances the permeability of lysosomal membranes, resulting in the release of lysosomal proteases, which contribute to mitochondrial membrane permeabilization and the lysosomal degradation mechanism of autophagic cell death. Although defects in apoptotic and non‐apoptotic cell death pathways can be carcinogenic, these pathways are more or less preserved within cancer cells and can therefore influence cell death and mediate resistance to cancer treatment. This paper discusses recent advances in determining the molecular mechanisms behind regulation of apoptotic and non‐apoptotic cell death, as well as the interplay between these two processes, which may lead to the development of new strategies by which to enhance the therapeutic effects of chemotherapeutic agents. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 62 references indexed in Scilit:
- Bcl-2 Attenuation of Oxidative Cell Death Is Associated with Up-regulation of γ-Glutamylcysteine Ligase via Constitutive NF-κB ActivationPublished by Elsevier ,2004
- Nuclear Factor-κB Mediates Up-Regulation of Cathepsin B by Doxorubicin in Tumor CellsMolecular Pharmacology, 2004
- Changes in Therapy for Solid Tumors: Potential for Overcoming Drug Resistance In Vivo with Molecular Targeting AgentsSurgery Today, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Inhibition of Bid-induced Apoptosis by Bcl-2Published by Elsevier ,2003
- BCL-2 Improves Oxidative Phosphorylation and Modulates Adenine Nucleotide Translocation in Mitochondria of Cells Harboring Mutant mtDNAPublished by Elsevier ,2003
- Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membraneThe Journal of cell biology, 2003
- Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)Biochemical and Biophysical Research Communications, 2002
- Human Papillomavirus Type 16 E6-enhanced Susceptibility of L929 Cells to Tumor Necrosis Factor α Correlates with Increased Accumulation of Reactive Oxygen SpeciesJournal of Biological Chemistry, 1999
- Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cellsOncogene, 1999